• A+ Standard
  • A+ Larger
  • A+ Extra Large

  • Standard Contrast
  • Low Contrast
  • High Contrast

The Brain Penetrant CDK4/6 Inhibitor, PRT3645, is Highly Effective in Combination With Other Targeted Therapies in Preclinical Models of NSCLC, CRC, and HER2-Positive Breast Cancer

Yue Zou, Srijita Dhar, Kirsten Gallagher, Andrew Buesking, Sarah Pawley, Ryan Holmes, Xiaowei Wu, Katarina Rohlfing, Min Wang, Joseph Rager, Tom Emm, Stefan Ruepp, Miles Cowart, Jing Ni, Jean Zhao, Bruce Ruggeri, Andrew Combs, Kris Vaddi, Sandy Geeganage, Ashish Juvekar, Sang Hyun Lee, Peggy Scherle

Poster presented at the

 AACR Annual Meeting 2023, April 14-19, 2023, Orlando, FL, USA

This is an electronic reproduction of a poster presented at the AACR Annual Meeting 2023, April 14-19, 2023, Orlando, FL, USA. All copyrights remain those of the copyright holder. This page will not be available after May 19, 2023.